Literature DB >> 8726829

Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

A Yamashita1.   

Abstract

The identification of nodular lesions, which used to be difficult to differentiate from well differentiated hepatocellular carcinomas, has become frequent since the advent of ultrasonic-guided liver tumor biopsy techniques. This is because adenomatous hyperplasias, which are regarded as putative precancerous lesions, which needed to be differentiated from malignant lesions, often an a nodular. The histological specimens of 52 tumors, obtained from patients with chronic liver injury, were subjected to immunohistological staining for proliferative cell nuclear antigen (PCNA). Findings obtained by this immunohistological technique were compared with those obtained by histological image analysis. Adenomatous hyperplasias with fatty changes or with a high nuclear cytoplasmic ratio on image analysis were frequently PCNA-positive (P < 0.01). These nodular lesions, whose morphological characteristics were similar to those of well differentiated hepatocellular carcinomas, showed a high potential for growth. It seems that PCNA may be a useful indicator for increasing our understanding of the progress from adenomatous hyperplasia to hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726829     DOI: 10.1007/BF02355027

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  16 in total

1.  Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality.

Authors:  F Kondo; M Ebara; N Sugiura; K Wada; K Kita; N Hirooka; Y Nagato; Y Kondo; M Ohto; K Okuda
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

2.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

3.  Ultrasound guided fine-needle biopsies in pancreatic and hepatic neoplasms.

Authors:  W B Schwerk; H K Dürr; P Schmitz-Moormann
Journal:  Gastrointest Radiol       Date:  1983

4.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  In vitro uptake of bromodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior.

Authors:  K Tarao; A Shimizu; M Harada; S Ohkawa; N Okamoto; Y Kuni; Y Ito; S Tamai; K Iimori; I Sugimasa
Journal:  Cancer       Date:  1991-10-15       Impact factor: 6.860

6.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

7.  Liver cell dysplasia: a premalignant condition.

Authors:  P P Anthony; C L Vogel; L F Barker
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

Review 8.  Adenomatous hyperplasia of the liver as a precancerous lesion.

Authors:  Y Nakanuma; T Terada; K Ueda; S Terasaki; A Nonomura; O Matsui
Journal:  Liver       Date:  1993-02

9.  Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma.

Authors:  A Eguchi; O Nakashima; S Okudaira; S Sugihara; M Kojiro
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

10.  Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients.

Authors:  M Ebara; M Ohto; N Sugiura; K Kita; M Yoshikawa; K Okuda; F Kondo; Y Kondo
Journal:  J Gastroenterol Hepatol       Date:  1990 Nov-Dec       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.